InvestorsHub Logo
icon url

Dimitrios George

07/05/13 11:24 AM

#8127 RE: markkind #8123

I agree Markkind, that was an AF rave.

You did not see him suggesting that Apricus was a $1 stock. His bottom line was: "Apricus believes this slice of patients is financially significant, but it's up to the company to prove it."

I am ok with that, but it will take a few months longer than we all hoped for to get to that point. And it is not just up to the company which admittedly is a little biotech. It is up to the likes of heavy hitters like Novartis and Takeda and Bracco....and Abbott if they can get their "bott" in gear.